Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


Distinct Molecular Trajectories Converge to Induce Naive Pluripotency.

Stuart HT, Stirparo GG, Lohoff T, Bates LE, Kinoshita M, Lim CY, Sousa EJ, Maskalenka K, Radzisheuskaya A, Malcolm AA, Alves MRP, Lloyd RL, Nestorowa S, Humphreys P, Mansfield W, Reik W, Bertone P, Nichols J, Göttgens B, Silva JCR.

Cell Stem Cell. 2019 Sep 5;25(3):388-406.e8. doi: 10.1016/j.stem.2019.07.009. Epub 2019 Aug 15.


Exit from Naive Pluripotency Induces a Transient X Chromosome Inactivation-like State in Males.

Sousa EJ, Stuart HT, Bates LE, Ghorbani M, Nichols J, Dietmann S, Silva JCR.

Cell Stem Cell. 2018 Jun 1;22(6):919-928.e6. doi: 10.1016/j.stem.2018.05.001. Epub 2018 May 24.


MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.

Barros-Silva D, Costa-Pinheiro P, Duarte H, Sousa EJ, Evangelista AF, Graça I, Carneiro I, Martins AT, Oliveira J, Carvalho AL, Marques MM, Henrique R, Jerónimo C.

Cell Death Dis. 2018 Feb 7;9(2):167. doi: 10.1038/s41419-017-0241-y.


SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3.

Vieira FQ, Costa-Pinheiro P, Almeida-Rios D, Graça I, Monteiro-Reis S, Simões-Sousa S, Carneiro I, Sousa EJ, Godinho MI, Baltazar F, Henrique R, Jerónimo C.

Oncotarget. 2015 May 30;6(15):13644-57.


Anti-neoplastic properties of hydralazine in prostate cancer.

Graça I, Sousa EJ, Costa-Pinheiro P, Vieira FQ, Torres-Ferreira J, Martins MG, Henrique R, Jerónimo C.

Oncotarget. 2014 Aug 15;5(15):5950-64.


Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer.

Baptista T, Graça I, Sousa EJ, Oliveira AI, Costa NR, Costa-Pinheiro P, Amado F, Henrique R, Jerónimo C.

Oncotarget. 2013 Oct;4(10):1673-85.


Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells.

Graça I, Sousa EJ, Baptista T, Almeida M, Ramalho-Carvalho J, Palmeira C, Henrique R, Jerónimo C.

Curr Pharm Des. 2014;20(11):1803-11.


Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing.

Sousa E, Graça I, Baptista T, Vieira FQ, Palmeira C, Henrique R, Jerónimo C.

Epigenetics. 2013 May;8(5):548-58. doi: 10.4161/epi.24519. Epub 2013 Apr 17.

Supplemental Content

Loading ...
Support Center